FTH1P2

Across TCGA pan-cancer cohorts, FTH1P2 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated FTH1P2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher FTH1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FTH1P2 expression acts as an unfavorable survival marker, although some lineages such as CESC and THCA show a favorable association.

UVM, KICH, and LUAD are the cancer types where FTH1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	All	0.554	0.841	<.001	111	view →
KICH	OS	Median	II,III,IV	0.603	1.000	<.001	100	view →
LUAD	OS	Tertile	All	0.563	0.765	.003	37	view →
CESC	DFS	Median	All	0.863	0.775	.010	36	view →
LIHC	OS	Tertile	All	0.688	0.873	.001	34	view →
HNSC	DFS	Quartile	All	0.617	0.757	.001	30	view →
KIRP	DFS	Tertile	All	0.579	0.791	.005	27	view →
THCA	OS	Median	II,III,IV	0.994	0.960	.008	21	view →
COAD	DFS	Median	IV	0.358	0.661	.003	21	view →
LAML	DFS	Quartile	All	0.269	0.546	.004	18	view →
UCEC	DFS	Quartile	All	0.870	0.935	.011	18	view →
STAD	DFS	Median	III,IV	0.412	0.551	.008	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

FTH1P2–UVM (OS)

Open the UVM breakdown →